Liquid Ibutamoren (MK 677) – 25MG/ML

Research-Grade Ghrelin Receptor Agonist for Laboratory Studies Ibutamoren, commonly referred to as MK-677, is a non-peptide ghrelin receptor agonist supplied exclusively for in-vitro and preclinical laboratory research. This compound is studied in controlled research environments to examine growth hormone secretagogue pathways, receptor signaling behavior, and endocrine regulation models. The liquid formulation allows for precise volumetric measurement in experimental settings. For research use only. Not for human or veterinary use. Scientific Context: What Is Ibutamoren (MK-677)? The ghrelin receptor (growth hormone secretagogue receptor, GHS-R1a) plays a central role in endocrine signaling related to growth hormone regulation, appetite signaling, and metabolic homeostasis. Endogenous ghrelin binds to this receptor to initiate downstream signaling cascades that influence hormonal release patterns. Ibutamoren is a small-molecule compound that interacts with the ghrelin receptor (GHS-R1a), making it a frequent subject of research related to growth hormone secretagogue mechanisms. Unlike peptide-based secretagogues, MK-677 is orally active and non-peptidic, which has made it useful in comparative research exploring:

Peptide vs non-peptide receptor activation Endocrine signaling pathways related to ghrelin Long-term receptor engagement models Hormonal regulation mechanisms in controlled systems

Its stability and molecular structure allow researchers to study ghrelin-mediated pathways without the degradation challenges associated with peptide compounds. What Distinguishes MK-677 in Research MK-677 is a small-molecule, non-peptide ghrelin receptor agonist, which distinguishes it from peptide-based secretagogues that are subject to rapid enzymatic degradation. From a chemical design perspective, MK-677 was developed to:

Maintain affinity for the ghrelin receptor Resist enzymatic breakdown associated with peptides Enable extended observation windows in research models